balanced salt solution enriched with bicarbonate, dextrose, and glutathione
BSS PLUS (balanced salt solution enriched with bicarbonate, dextrose, and glutathione) by Alcon is clinical pharmacology none of the components of bss plus are foreign to the eye. First approved in 1981.
Drug data last refreshed 13h ago · AI intelligence enriched 1w ago
BSS PLUS is an intraocular irrigation solution enriched with bicarbonate, dextrose, and glutathione, designed to maintain corneal endothelial integrity and retinal electrical activity during ophthalmic surgery. It is used as an adjunctive agent during procedures such as vitrectomy, phacoemulsification, and cataract extraction. The formulation provides physiologic pH, ionic composition, and metabolic support to ocular tissues during surgical manipulation.
Product is in late lifecycle stage with moderate competitive pressure (30%), indicating potential team restructuring or transition planning within the ophthalmology franchise.
CLINICAL PHARMACOLOGY None of the components of BSS PLUS are foreign to the eye. Human perfused cornea studies have shown BSS PLUS to be an effective irrigation solution for providing corneal detumescence and maintaining corneal endothelial integrity during intraocular perfusion. An in vivo study…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Safety of NGOIS Compared to BSS Plus in Pediatric Patients
Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus
Worked on BSS PLUS at Alcon? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on BSS PLUS offers experience in mature ophthalmic product management within a legacy franchise under Alcon, with focus on maintaining market share and managing the transition toward loss of exclusivity. Career growth may be limited by the product's lifecycle stage, but roles provide solid foundation in surgical ophthalmology, hospital relationships, and device-drug combination strategy.